Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$BYND, $BNTX, $CURLF, $LMT, $LULU, $NEM, $RGLD, $SCCO, $VRTX

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Wednesday, 20 May, as follows:

Beyond Meat Inc. (NASDAQ:BYND) was started with a Buy rating and a 173 price target at BTIG.

BioNTech S.E. (NASDAQ:BNTX) was upgraded to Buy from Neutral and its price target was raised to 69 from 48 at HC Wainwright.

Curaleaf Holdings Inc. (NASDAQ:CURLF) was reiterated as Buy and its price target was raised to 10 from 6 at Needham.

General Dynamics Corp. (NYSE:GD) was started with a Buy rating and a 188 price target at Seaport Global.

Lockheed Martin Corp. (NYSE:LMT) was started with a Buy rating and a $435 price target at Seaport Global.

Lululemon Athletica Inc. (NASDAQ:LULU) was reiterated as Buy and its price target was raised to 290 from 256 at B. Riley FBR.

Newmont Corp. (NYSE:NEM) was reiterated as Buy and its price target was raised to 97 from 96 at B. Riley FBR.

Royal Gold Inc. (NASDAQ:RGLD) was reiterated as Buy and the price target was raised to 151 from 150 at B Riley FBR.

Southern Copper Corp. (NYSE:SCCO) was reiterated as Buy and its price target was raised to 40 from 38 at UBS.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX): the champ of cystic fibrosis is about to repeat another year of 37% revenue growth. Shares have a consensus price target of 283.91.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge. Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.